2023
DOI: 10.18553/jmcp.2023.29.5-a.s2
|View full text |Cite
|
Sign up to set email alerts
|

Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 43 publications
0
15
0
Order By: Relevance
“… 24 In AMD, particularly GA, inflammation plays a crucial role in the degenerative process. 25 , 26 Our control showed that retinal microglia are mainly located in the GCL and IPL. However, we observed the migration of macrophages and microglia into the ONL layer at all time points in NaIO 3 -injected rats.…”
Section: Discussionmentioning
confidence: 80%
“… 24 In AMD, particularly GA, inflammation plays a crucial role in the degenerative process. 25 , 26 Our control showed that retinal microglia are mainly located in the GCL and IPL. However, we observed the migration of macrophages and microglia into the ONL layer at all time points in NaIO 3 -injected rats.…”
Section: Discussionmentioning
confidence: 80%
“…With age, RPE dysfunction progresses, leading to drusen and lipofuscin deposition [11,39]. Drusen and lipofuscin components, as well as other oxidative stress products, such as advanced glycation end products, have been reported to induce inflammation through multiple pathways, including via the complement cascade [39][40][41][42]. When regulatory components in these pathways are compromised, especially by genetic risk factors, initiation of chronic inflammation (para-inflammation) may lead to damage and, ultimately, retinal cell death, which is a typical feature of GA [11,42].…”
Section: Discussionmentioning
confidence: 99%
“…Retinal pathology problems that were investigated in this study were: retinal pigmented epithelium (RPE) change, drusen, geographic atrophy (GA), HTR, nonproliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR), choroidal neovascularization (CNV), central retinal artery occlusion (CRAO), myopic retinopathy (MR), branch retinal vein occlusion (BRVO), and central retinal vein occlusion (CRVO). Each evaluated retinal pathology is defined in Table 1 [14][15][16][17][18][19][20][21][22][23][24] . Statistical Analysis The prevalence of retinal pathologies is reported as percentage and 95% confidence interval.…”
Section: Subjects and Methods Ethical Approvalmentioning
confidence: 99%
“…Drusen Yellow deposits under the retina [14] Retinal pigmented epithelium change Change in the pigmentation of the RPE [15] Geographic atrophy Atrophic lesions in the macula [16] Choroidal neovascularization New blood vessels originating from the choroid [17] Nonproliferative diabetic retinopathy The presence of at least one sign including microaneurysms, dot and blot and intraretinal hemorrhages, hard exudates, cotton-wool spots, and venous beading in diabetic patients [18][19] Proliferative diabetic retinopathy The presence of new vessels with or without intravitreal hemorrhages in diabetic patients [19] Hypertensive retinopathy 1 or more signs including generalized arteriolar narrowing, focal arteriolar narrowing, arteriovenous nicking, arteriolar wall opacity, retinal hemorrhage (blot, dot, flame-shaped), microaneurysm, cotton wool spot, hard exudate, moderate retinopathy plus optic disc swelling in patients with hypertension [20]…”
Section: Retinal Pathologies Definitionmentioning
confidence: 99%